The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.
Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.
Romania's pharmaceutical sector demonstrates resilience despite fiscal consolidation and slowing economic growth, according to Allianz Trade's latest analysis.
Energy company Electrica informs investors and the capital market that it has obtained the technical grid connection permits (ATR) for 17 new battery energy storage projects (BESS), with a total capacity of approximately 700 MWh.
The European Retail Banking Radar, Kearney's latest study now in its 18th edition, shows that Europe is entering a period of normalisation following the conditions of 2023–2025. For Romania, the challenge extends beyond the normalisation of interest rates.
Digi Spain has announced its intention to launch an initial public offering (IPO) on the Spanish stock exchanges, aiming to raise approximately €150 million.
Romania's national electricity transmission network operator, Transelectrica, has halted scheduled maintenance shutdowns to ensure the grid operates at maximum capacity during an ongoing extreme heatwave. The preventive measures aim to mitigate operational risks associated with severe weather conditions.
The European Commission has approved, under EU State aid rules, Romanian measures for the national investment and development bank Banca de Investiții și Dezvoltare (BID).